{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T06:08:55Z","timestamp":1781417335439,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cjca.2017.01.011","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T05:31:07Z","timestamp":1484976667000},"page":"635-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Calcium Channel Blockers on Major Cardiovascular Outcomes for the Treatment of Hypertension in Asian Populations: A Meta-analysis"],"prefix":"10.1016","volume":"33","author":[{"given":"Karen C.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hude","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2017.01.011_bib1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/IBPC.S74320","article-title":"Personalized medicine and treatment approaches in hypertension: current perspectives","volume":"9","author":"Byrd","year":"2016","journal-title":"Integr Blood Press Control"},{"key":"10.1016\/j.cjca.2017.01.011_bib2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11739-016-1422-x","article-title":"Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity","volume":"11","author":"Brewster","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cjca.2017.01.011_bib3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.2174\/1381612820666141024125325","article-title":"Drugs affecting blood pressure variability: an update","volume":"21","author":"Hocht","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cjca.2017.01.011_bib4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.amjhyper.2003.09.008","article-title":"Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients","volume":"17","author":"Eguchi","year":"2004","journal-title":"Am J Hypertens"},{"issue":"suppl 2","key":"10.1016\/j.cjca.2017.01.011_bib5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/dmrr.2356","article-title":"Characteristics of hypertension in Chinese and their relevance for the choice of antihypertensive drugs","volume":"28","author":"Wang","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.cjca.2017.01.011_bib6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/hr.2010.259","article-title":"Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association","volume":"34","author":"Wang","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjca.2017.01.011_bib7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.107.089763","article-title":"Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview","volume":"50","author":"Wang","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2017.01.011_bib8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000382025","article-title":"Chinese hypertension guidelines","volume":"3","author":"Wang","year":"2015","journal-title":"Pulse (Basel)"},{"key":"10.1016\/j.cjca.2017.01.011_bib9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1370\/afm.708","article-title":"Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review","volume":"5","author":"Park","year":"2007","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.cjca.2017.01.011_bib10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.HYP.34.5.1129","article-title":"Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group","volume":"34","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2017.01.011_bib11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1291\/hypres.27.181","article-title":"Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial","volume":"27","author":"Yui","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjca.2017.01.011_bib12","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjca.2017.01.011_bib13","unstructured":"Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.handbook.cochrane.org. Accessed August 7, 2016."},{"key":"10.1016\/j.cjca.2017.01.011_bib14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.cjca.2017.01.011_bib15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","article-title":"Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial","volume":"51","author":"Ogihara","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2017.01.011_bib16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/hr.2010.186","article-title":"Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial","volume":"34","author":"Narumi","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjca.2017.01.011_bib17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/HYPERTENSIONAHA.111.184226","article-title":"Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study","volume":"59","author":"Muramatsu","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2017.01.011_bib18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/hr.2012.125","article-title":"Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure","volume":"35","author":"Asayama","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjca.2017.01.011_bib19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.amjmed.2011.12.010","article-title":"Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients","volume":"125","author":"Ogawa","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2017.01.011_bib20","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1097\/HJH.0000000000000281","article-title":"Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a\u00a0randomized, controlled trial","volume":"32","author":"Ogihara","year":"2014","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjca.2017.01.011_bib21","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1161\/HYPERTENSIONAHA.113.02200","article-title":"Concerns for the heart failure reduction in the NAGOYA HEART study based on meta-regression from the evidence","volume":"62","author":"Takagi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2017.01.011_bib22","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2017.01.011_bib23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jash.2013.09.002","article-title":"Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA)","volume":"8","author":"Yano","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.cjca.2017.01.011_bib24","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/bmj.38803.528113.55","article-title":"Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine","volume":"332","author":"McDowell","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2017.01.011_bib25","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1097\/01.hjh.0000249692.96488.46","article-title":"Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial","volume":"24","author":"Zanchetti","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjca.2017.01.011_bib26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.011_bib27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the\u00a0ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2017.01.011_bib28","first-page":"1033","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack [errata in 2001;358:1556, 2002;359:2120]","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2017.01.011_bib29","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.011_bib30","unstructured":"Statistics Canada. Available at: http:\/\/www.statcan.gc.ca. Accessed September 18, 2016."},{"key":"10.1016\/j.cjca.2017.01.011_bib31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cjca.2015.04.027","article-title":"The risk of ischemic heart disease and stroke among immigrant populations: a systematic review","volume":"31","author":"Sohail","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.01.011_bib32","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.cjca.2015.06.008","article-title":"Cardiovascular disease in South Asian migrants","volume":"31","author":"Fernando","year":"2015","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17300156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17300156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T23:26:22Z","timestamp":1536103582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X17300156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0828282X17300156"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2017.01.011","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Calcium Channel Blockers on Major Cardiovascular Outcomes for the Treatment of Hypertension in Asian Populations: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2017.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}